Compare VATE & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VATE | BTMD |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.0M | 65.4M |
| IPO Year | N/A | N/A |
| Metric | VATE | BTMD |
|---|---|---|
| Price | $5.14 | $2.07 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 16.6K | ★ 155.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.37 |
| P/E Ratio | ★ N/A | $2.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.05 | $2.02 |
| 52 Week High | $13.19 | $5.00 |
| Indicator | VATE | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 38.96 |
| Support Level | $5.15 | $2.02 |
| Resistance Level | $5.54 | $2.19 |
| Average True Range (ATR) | 0.31 | 0.14 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 11.24 | 14.08 |
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.